Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Sold by Washington Trust Advisors Inc.

Washington Trust Advisors Inc. reduced its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 1.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 32,225 shares of the biopharmaceutical company’s stock after selling 371 shares […]

Related Keywords

Canada ,Washington ,United States ,Marion Mccourt ,Josephl Goldstein ,Meyer Handelman Co ,Exchange Traded Concepts ,Nasdaq ,Stifel Financial Corp ,Royal Bank ,Regeneron Pharmaceuticals ,Quarter For Regeneron Pharmaceuticals ,Securities Exchange Commission ,News Ratings For Regeneron Pharmaceuticals Daily ,Washington Trust Advisors Inc ,Cavalier Investments ,Exchange Commission ,Barclays ,Regeneron Pharmaceuticals Trading ,Regeneron Pharmaceuticals Inc ,Washington Trust Advisors ,Free Report ,Trust Advisors ,Financial Corp ,Traded Concepts ,Director Joseph ,Get Free Report ,Regeneron Pharmaceuticals Daily ,